Citations (24)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Jiaqi Shan & Hongbin Sun. (2013)
The discovery and development of prasugrel
. Expert Opinion on Drug Discovery 8:7, pages 897-905.
Read now
Read now
K. Hagihara, M. Kazui, H. Ikenaga, T. Nanba, K. Fusegawa, M. Takahashi, A. Kurihara, O. Okazaki, N. A Farid & T. Ikeda. (2009) Comparison of formation of thiolactones and active metabolites of prasugrel and clopidogrel in rats and dogs. Xenobiotica 39:3, pages 218-226.
Read now
Read now
K. Hagihara, A. Kurihara, K. Kawai, M. Kazui, M. Takahashi, K. Kawabata, N. A. Farid & T. Ikeda. (2007) Absorption, distribution and excretion of the new thienopyridine agent prasugrel in rats. Xenobiotica 37:7, pages 788-801.
Read now
Read now
Articles from other publishers (21)
Benjamin M. Brainard & Sarah B. Shropshire. 2023. Small Animal Critical Care Medicine. Small Animal Critical Care Medicine
937
942
.
Alexandra Pfaff, Armelle M. de Laforcade & Elizabeth A. Rozanski. (2020) The Use of Antithrombotics in Critical Illness. Veterinary Clinics of North America: Small Animal Practice 50:6, pages 1351-1370.
Crossref
Crossref
Steven W. Baertschi, Lindsay Maxwell-Backer, Matthew Clemens, Tim A. Smitka, Jerry R. Draper, K. Wayne Taylor, Andreas Kaerner & Patrick J. Jansen. (2019) The Degradation Chemistry of Prasugrel Hydrochloride: Part 1—Drug Substance. Journal of Pharmaceutical Sciences 108:9, pages 2842-2857.
Crossref
Crossref
Patrick M. Dansette, Dan Levent, Assia Hessani & Daniel Mansuy. (2015) Bioactivation of Clopidogrel and Prasugrel: Factors Determining the Stereochemistry of the Thiol Metabolite Double Bond. Chemical Research in Toxicology 28:6, pages 1338-1345.
Crossref
Crossref
Mahmoud M.H. Al Omari, Nidal A. Qinna, Iyad S. Rashid, Khaldoun A. Al-Sou’od & Adnan A. Badwan. 2015.
195
320
.
Benjamin M. Brainard. 2015. Small Animal Critical Care Medicine. Small Animal Critical Care Medicine
877
882
.
Patrick M. Dansette, Julien Rosi, Justine Debernardi, Gildas Bertho & Daniel Mansuy. (2012) Metabolic Activation of Prasugrel: Nature of the Two Competitive Pathways Resulting in the Opening of Its Thiophene Ring. Chemical Research in Toxicology 25:5, pages 1058-1065.
Crossref
Crossref
Alexander V. LyubimovBernard Testa & André Pannatier. 2011. Encyclopedia of Drug Metabolism and Interactions. Encyclopedia of Drug Metabolism and Interactions
1
23
.
Bo Wiinberg, Lisbeth R. Jessen, Inge Tarnow & Annemarie T. Kristensen. (2012) Diagnosis and treatment of platelet hyperactivity in relation to thrombosis in dogs and cats. Journal of Veterinary Emergency and Critical Care 22:1, pages 42-58.
Crossref
Crossref
Minoru Uchiyama, Hiroko Koda, Thomas Fischer, Juergen Mueller, Naotoshi Yamamura, Minoru Oguchi, Haruo Iwabuchi, Osamu Okazaki & Takashi Izumi. (2011) In Vitro Metabolism of Rivoglitazone, a Novel Peroxisome Proliferator-Activated Receptor γ Agonist, in Rat, Monkey, and Human Liver Microsomes and Freshly Isolated Hepatocytes. Drug Metabolism and Disposition 39:7, pages 1311-1319.
Crossref
Crossref
David S. Small, Nagy A. Farid, Christopher D. Payne, Christopher S. Konkoy, Joseph A. Jakubowski, Kenneth J. Winters & Daniel E. Salazar. (2010) Effect of Intrinsic and Extrinsic Factors on the Clinical Pharmacokinetics and Pharmacodynamics of Prasugrel. Clinical Pharmacokinetics 49:12, pages 777-798.
Crossref
Crossref
Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara, Haruo Iwabuchi, Minoru Ishikawa, Hiroyuki Kobayashi, Naoki Tanaka, Osamu Okazaki, Nagy A. Farid & Toshihiko Ikeda. (2010) Biotransformation of Prasugrel, a Novel Thienopyridine Antiplatelet Agent, to the Pharmacologically Active Metabolite. Drug Metabolism and Disposition 38:6, pages 898-904.
Crossref
Crossref
L. Testa, R. Bhindi, W. J. Van Gaal, R. A. Latini, S. Pizzocri, S. Lanotte, G. G. L. Biondi Zoccai, M. Valgimigli, M. L. Laudisa, N. Brambilla, A. P. Banning & F. Bedogni. (2010) What is the risk of intensifying platelet inhibition beyond clopidogrel? A systematic review and a critical appraisal of the role of prasugrel. QJM 103:6, pages 367-377.
Crossref
Crossref
Nagy A. Farid, Atsushi Kurihara & Steven A. Wrighton. (2013) Metabolism and Disposition of the Thienopyridine Antiplatelet Drugs Ticlopidine, Clopidogrel, and Prasugrel in Humans. The Journal of Clinical Pharmacology 50:2, pages 126-142.
Crossref
Crossref
L. Testa, G. G. L. Biondi Zoccai, M. Valgimigli, R. A. Latini, S. Pizzocri, S. Lanotte, M. L. Laudisa, N. Brambilla, M. R. Ward, G. A. Figtree, F. Bedogni & R. Bhindi. (2010) Current Concepts on Antiplatelet Therapy: Focus on the Novel Thienopyridine and Non-Thienopyridine Agents. Advances in Hematology 2010, pages 1-7.
Crossref
Crossref
Katsunobu Hagihara, Miho Kazui, Atsushi Kurihara, Michiharu Yoshiike, Kokichi Honda, Osamu Okazaki, Nagy A. Farid & Toshihiko Ikeda. (2009) A Possible Mechanism for the Differences in Efficiency and Variability of Active Metabolite Formation from Thienopyridine Antiplatelet Agents, Prasugrel and Clopidogrel. Drug Metabolism and Disposition 37:11, pages 2145-2152.
Crossref
Crossref
Bernard Testa. (2009) Drug Metabolism for the Perplexed Medicinal Chemist. Chemistry & Biodiversity 6:11, pages 2055-2070.
Crossref
Crossref
Bernard Testa & Stefanie D. Krämer. (2009) The Biochemistry of Drug Metabolism – An Introduction. Chemistry & Biodiversity 6:5, pages 591-684.
Crossref
Crossref
Patrick M. Dansette, Julie Libraire, Gildas Bertho & Daniel Mansuy. (2009) Metabolic Oxidative Cleavage of Thioesters: Evidence for the Formation of Sulfenic Acid Intermediates in the Bioactivation of the Antithrombotic Prodrugs Ticlopidine and Clopidogrel. Chemical Research in Toxicology 22:2, pages 369-373.
Crossref
Crossref
Dennis A. Smith & R. Scott Obach. (2009) Metabolites in Safety Testing (MIST): Considerations of Mechanisms of Toxicity with Dose, Abundance, and Duration of Treatment. Chemical Research in Toxicology 22:2, pages 267-279.
Crossref
Crossref
Nuggehally R. Srinivas. (2009) Pharmacokinetic Screening Strategy for Discovery Work-Use of Rodent Species: Lessons Learnt and Probing Newer Thoughts. Drug Metabolism and Pharmacokinetics 24:2, pages 197-198.
Crossref
Crossref